Jeffs’ Brands has signed a non-binding letter of intent regarding, among other things, the integration of AI-based tools developed by B24Chat. This will strengthen Jeffs’ Brands’ internal marketing system and upgrade its marketing and services. performance
TEL AVIV, Israel, July 7, 2023 (Globe Newswire) — Medigs Limited (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative Internet technologies, electric vehicles and charging solutions, today announced that Jeffs Brands Limited (“Jeffs Brands”) (34.87% owned by Medigs) ) announced the establishment of The company, a data-driven e-commerce company operating on the Amazon marketplace, has issued a non-binding statement of intent to acquire majority control of its B24Chat business, an enterprise-level, omnichannel-focused AI marketing platform. (“LOI”). Conversational automation management.
Entry into LOI and resulting planned transaction aligns with Jeffs’ Brands’ commitment to strengthen internal marketing and service capabilities and leverage cutting-edge technology to drive revenue growth .
This acquisition marks Jeffs’ Brands’ strategic entry into the AI space, complementing its existing set of businesses. B24Chat, an AI-based customer service platform, provides omnichannel and conversational automation management solutions that enable businesses to streamline customer interactions across various platforms.
Pursuant to the LOI and subject to execution of the definitive agreement, the parties will form a new company (“NewCo”) in which Jeffs’ Brands will invest a total of $1,000,000, of which $500,000 will be paid in cash and $500,000 will be paid. increase. His 50.01% of NewCo’s fully diluted share capital was paid in newly issued ordinary shares of Jeffs’ Brands as consideration. The founder of B24Chat shall transfer all right, title and interest in and to the technology of the B24Chat business in consideration of his 49.99% of NewCo’s fully diluted share capital.
The B24Chat platform provides the ability for businesses to build and operate private branded, sales-focused websites and easy-to-use iOS and Android apps. By connecting to corporate websites, customer relationship management (CRM), and/or enterprise resource planning (ERP), B24Chat’s smart bots “read” and “see” content to gather information about products and services or update news. company and market. Bots learn on their own and develop their own scenarios to prepare for conversations with clients.
About Medigas
Israel-based Medigus Ltd. (Nasdaq: MDGS) is a technology company focused primarily on innovative and growing partnerships in the advanced medical solutions, digital commerce and electric vehicle markets. Medigas partnerships in the medical solutions space include ownership of Polyrizon Ltd. and ScoutCam Inc., an Industry 4.0 company. The company’s digital commerce affiliates include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. Markets, Charging Robotics Ltd. and Revoltz Ltd. are also part of our portfolio of technology solution providers. For more information on Medigus advanced technology, please visit http://www.medigus.com/.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain “forward-looking statements” that are based on Medigas management’s current estimates, assumptions and expectations and knowledge of the relevant market. Wherever possible, we ‘anticipate’, ‘believe’, ‘imagine’, ‘estimate’, ‘expect’, ‘intend’, ‘may’, ‘plan’, ‘forecast’ will, “plan,” “target,” “could,” “would,” “would,” “could,” “should,” “continue,” ” “contemplate” and other similar expressions and derivatives any discussion of future events, trends, prospects or future operating or financial performance. However, not all forward-looking statements contain these specific language. These forward-looking statements represent Medigs’ expectations or beliefs regarding future events and may not achieve the results described in this press release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause future results from Medigs’ activities to differ materially from those expressed in such statements. I have. Additional risk factors affecting Medigs are detailed in Medigs’ filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and Medigs undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. I don’t owe you. Neither Medigus nor its stockholders, officers and employees shall be liable for any actions taken by any person based on the information contained herein and the consequences thereof (including without limitation the purchase or sale of Medigus securities). shall be
Company contact:
Talidinar
CFO
+972-8-6466-880
ir@medigus.com
